In the BioHarmony Drug Report Database
Epirubicin
Ellence, Epirubicin (epirubicin) is a small molecule pharmaceutical. Epirubicin was first approved as Ellence on 1999-09-15. It is used to treat breast neoplasms in the USA.
Trade Name
|
Ellence, Epirubicin |
|---|---|
Common Name
|
epirubicin |
ChEMBL ID
|
CHEMBL417 |
Indication
|
breast neoplasms |
Drug Class
|
Antineoplastic antibiotics (daunorubicin type) |
Image (chem structure or protein)